Document is current
Any future updates will be listed below
-
Authors
Engwicht, E.
Petersen, J.
Braehler, E.
Wicke, F.
Koenig, J.
Muenzel, T.
Schuster, A. K.
Lackner, K.
Wild, P. S.
Beutel, M. E.
Hettich-Damm, Nora
-
Funding
Funding for this research was provided by:
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
- License Information
-
More Information
Article History
Received: 24 June 2024
Accepted: 14 July 2025
First Online: 22 July 2025
Declarations
:
: Outside the submitted work, P.S.W. reports grants from Bayer AG, non-financial grants from Philips Medical Systems, grants and consulting fees from Boehringer Ingelheim, grants and consulting fees from Novartis Pharma, grants and consulting fees from Sanofi-Aventis, grants, consulting and lecturing fees from Bayer Health Care, grants and consulting fees from Daiichi Sankyo Europe, lecturing fees from Pfizer Pharma, lecturing fees from Bristol Myers Squibb, consulting fees from Astra Zeneca, consulting fees and non-financial support from Diasorin and non-financial support from I.E.M. P.S.W is funded by the Federal Ministry of Education and Research (BMBF 01EO1503), he is PI of the German Center for Cardiovascular Research (DZHK) and principal investigator of the DIASyM research core (BMBF DIASyM research core (BMBF 161L0217A). Schuster AK received financial and research support from Allergan, Bayer, Heidelberg Engineering, PlusOptix and Novartis. He received consulting fees from Apellis. All the remaining authors declare no conflict of interest.
